BOT is now approaching a $250 million market and has added more than $100 million of market cap following their successful phase 1a results.
IHL has a MC of $25 million and about to commence four independent clinical trials. There’s no more capital required so the only way to be part of the story is to buy in the market.
BOT is now approaching a $250 million market and has added more...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)